🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lakshmi Rajdev

Icahn School of Medicine at Mount Sinai

ORCID: 0009-0005-9747-6121
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.147Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

COVID-19 Clinical Research

Journal of Cellular Signaling(2020)10.33696/signaling.1.006
Top 70%
0.147DataRank
Top 70%1 citations

David W. Chitty, Mee-Young Lee, Nausheen Hakim, Shamsah Lakhani, Lakshmi Rajdev +3 more

Papers

Driven by 10 papers — median percentile 30. Top paper: “Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010.”.

Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4500
N/A
2.3DataRank · unranked
36 citations

Kathryn Winter, Dennis A. Wigle, Thomas A. DiPetrillo, Michael G. Haddock, Theodore S. Hong +15 more

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00718-x
N/A
0.700DataRank · unranked
105 citations

Kathryn Winter, David H Ilson, Dennis Wigle, Thomas DiPetrillo, Michael G Haddock +17 more

A phase II/III study of peri-operative nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of the neoadjuvant pathologic complete response (pCR) rate (ECOG-ACRIN EA2174).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.4000
N/A
0.477DataRank · unranked
23 citations

Noah Graham, Michael K. Gibson, Lakshmi Rajdev, Anuradha Chakravarthy, Onkar V. Khullar +13 more

Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study

Cancer(2023)10.1002/cncr.35110
N/A
0.449DataRank · unranked
19 citations

Chia-Ching J. Wang, Himanshu Joshi, Shelly Lensing, Jeannette Y. Lee, Juan Carlos Ramos +14 more

A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of a safety run-in—A trial of the ECOG-ACRIN Cancer Research Group (EA2174).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4064
N/A
0.396DataRank · unranked
13 citations

Michelle Weitz, Paul J. Catalano, Michael K. Gibson, Lakshmi Rajdev, Onkar V. Khullar +15 more

A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: A trial of the ECOG-ACRIN Cancer Research Group (EA2174).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps4651
N/A
0.373DataRank · unranked
11 citations

Michelle Weitz, Michael K. Gibson, Lakshmi Rajdev, Onkar V. Khullar, Steven H. Lin +13 more

EA2183: A phase III study of consolidative radiotherapy in patients with oligometastatic HER2-negative esophageal and gastric adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4162
N/A
0.272DataRank · unranked
3 citations

Noah Graham, Lakshmi Rajdev, Michael K. Gibson, George A. Fisher, Steven H. Lin +3 more

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-22-0516
N/A
0.216DataRank · unranked
2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Priya Kumthekar +16 more

NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad143
N/A
0.165DataRank · unranked
2 citations

Rebecca C. Auer, May Cho, N.A. Dasari, Cynthia Davies-Venn, Cathy Eng +36 more

COVID-19 Clinical Research

Journal of Cellular Signaling(2020)10.33696/signaling.1.006
Top 70%
0.147DataRank
Top 70%1 citations

David W. Chitty, Mee-Young Lee, Nausheen Hakim, Shamsah Lakhani, Lakshmi Rajdev +3 more